Tetraspanin protein contributions to cancer

Biochemical Society Transactions

Volumn 39, Issue 2, 2011, Pages 547-552

  Wang, Hong Xing ^a   Li, Qinglin ^a   Sharma, Chandan ^a   Knoblich, Konstantin ^a   Hemler, Martin E ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

4 integrin; A disintegrin and metalloproteinase 10 (ADAM10); CD151; CD9; EWI 2; EWI F; Tetraspanin; Tspan12

Indexed keywords

ADAM10 ENDOPEPTIDASE; ALPHA6BETA4 INTEGRIN; CD151 ANTIGEN; CD9 ANTIGEN; DISINTEGRIN; EWI 2 PROTEIN; EWI F PROTEIN; MEMBRANE PROTEIN; TETRASPANIN; TSPAN12 PROTEIN; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 6;

CANCER INHIBITION; CANCER INVASION; CHEMOSENSITIVITY; GENE MUTATION; HUMAN; METASTASIS; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; VITREORETINOPATHY;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ANTIGENS, CD; HUMANS; INTEGRINS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; NEOPLASMS; PROTEIN BINDING;

EID: 79953195584     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0390547     Document Type: Review

References (79)

1. Sincock, P.M., Mayrohofer, G. and Ashman, L.K. (1997) Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues: comparison with CD9, CD63, and α5β1 integrin. J. Histochem. Cytochem. 45, 515-525 (Pubitemid 27175796)
2. Wright, M.D., Geary, S.M., Fitter, S., Moseley, G.W., Lau, L.M., Sheng, K.C., Apostolopoulos, V., Stanley, E.G., Jackson, D.E. and Ashman, L.K. (2004) Characterization of mice lacking the tetraspanin superfamily member CD151. Mol. Cell. Biol. 24, 5978-5988
3. Takeda, Y., Kazarov, A.R., Butterfield, C.E., Hopkins, B.D., Benjamin, L.E., Kaipainen, A. and Hemler, M.E. (2007) Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro. Blood 109, 1524-1532 (Pubitemid 46239585)
4. Sachs, N., Kreft, M., Van Den Bergh Weerman, MA, Beynon, A.J., Peters, T.A., Weening, J.J. and Sonnenberg, A. (2006) Kidney failure in mice lacking the tetraspanin CD151. J. Cell Biol. 175, 33-39 (Pubitemid 44537196)
5. Baleato, R.M., Guthrie, P.L., Gubler, M.C., Ashman, L.K. and Roselli, S. (2008) Deletion of CD151 results in a strain-dependent glomerular disease due to severe alterations of the glomerular basement membrane. Am. J. Pathol. 173, 927-937
6. Cowin, A.J., Adams, D., Geary, S.M., Wright, M.D., Jones, J.C. and Ashman, L.K. (2006) Wound healing is defective in mice lacking tetraspanin CD151. J. Invest. Dermatol. 126, 680-689
7. Karamatic, CV, Burton, N., Kagan, A., Green, C.A., Levene, C., Flinter, F., Brady, L.R., Daniels, G. and Anstee, D.J. (2004) CD151, the first member of the tetraspanin (TM4) superfamily detected on erythrocytes, is essential for the correct assembly of human basement membranes in kidney and skin. Blood 104, 2217-2223 (Pubitemid 39331816)
8. Kagan, A., Feld, S., Chemke, J. and Bar-Khayim, Y. (1988) Occurrence of hereditary nephritis, pretibial epidermolysis bullosa and β-thalassemia minor in two siblings with end-stage renal disease. Nephron 49, 331-332
9. Sterk, L.M., Geuijen, C.A., Van Den Berg, J.G., Claessen, N., Weening, J.J. and Sonnenberg, A. (2002) Association of the tetraspanin CD151 with the laminin-binding integrins α3β1, α6β1, α6β4 and β7α1 in cells in culture and in vivo. J. Cell Sci. 115, 1161-1173 (Pubitemid 34272481)
10. Yauch, R.L., Berditchevski, F., Harler, M.B., Reichner, J. and Hemler, M.E. (1998) Highly stoichiometric, stable and specific association of integrin α3β1 with CD151 provides a major link to phosphatidylinositol 4-kinase and may regulate cell migration. Mol. Biol. Cell 9, 2751-2765
11. Zhang, X.A., Bontrager, A.L. and Hemler, M.E. (2001) TM4SF proteins associate with activated PKC and link PKC to specific β1 integrins. J. Biol. Chem. 276, 25005-25013
12. Hemler, M.E. (2005) Tetraspanin functions and associated microdomains. Nat. Rev. Mol. Cell Biol. 6, 801-811
13. Liu, L., He, B., Liu, W.M., Zhou, D., Cox, J.V. and Zhang, X.A. (2007) Tetraspanin CD151 promotes cell migration by regulating integrin trafficking. J. Biol. Chem. 282, 31631-31642
14. Desgrosellier, J.S. and Cheresh, D.A. (2010) Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 10, 9-22
15. Zoller, M. (2009) Tetraspanins: push and pull in suppressing and promoting metastasis. Nat. Rev. Cancer 9, 40-55
16. Klosek, S.K., Nakashiro, K., Hara, S., Goda, H., Hasegawa, H. and Hamakawa, H. (2009) CD151 regulates HGF-stimulated morphogenesis of human breast cancer cells. Biochem. Biophys. Res. Commun. 379, 1097-1100
17. Sadej, R., Romanska, H., Baldwin, G., Gkirtzimanaki, K., Novitskaya, V., Filer, A.D., Krcova, Z., Kusinska, R., Ehrmann, J., Buckley, C.D. et al. (2009) CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium. Mol. Cancer Res. 7, 787-798
18. Sadej, R., Romanska, H., Kavanagh, D., Baldwin, G., Takahashi, T., Kalia, N. and Berditchevski, F. (2010) Tetraspanin CD151 regulates transforming growth factor β signaling: implication in tumor metastasis. Cancer Res. 70, 6059-6070
19. Ke, A.W., Shi, G.M., Zhou, J., Wu, F.Z., Ding, Z.B., Hu, M.Y., Xu, Y., Song, Z.J., Wang, Z.J., Wu, J.C. et al. (2009) Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology 49, 491-503
20. Shi, G.M., Ke, A.W., Zhou, J., Wang, X.Y., Xu, Y., Ding, Z.B., Devbhandari, R.P., Huang, X.Y., Qiu, S.J., Shi, Y.H. et al. (2010) CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma. Hepatology 52, 183-196
21. Zijlstra, A., Lewis, J., Degryse, B., Stuhlmann, H. and Quigley, J.P. (2008) The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. Cancer Cell 13, 221-234 (Pubitemid 351318371)
22. Yang, X.H., Richardson, A.L., Torres-Arzayus, M.I., Zhou, P., Sharma, C., Kazarov, A.R., Andzelm, M.M., Strominger, J.L., Brown, M. and Hemler, M.E. (2008) CD151 accelerates breast cancer by regulating α6 integrin functions, signaling, and molecular organization. Cancer Res. 68, 3204-3213
23. Yang, X.H., Flores, L.M., Li, Q., Zhou, P., Xu, F., Krop, I.E. and Hemler, M.E. (2010) Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists. Cancer Res. 70, 2256-2263
24. Rabinovitz, I., Tsomo, L. and Mercurio, A.M. (2004) Protein kinase Cα phosphorylation of specific serines in the connecting segment of the β4 integrin regulates the dynamics of type II hemidesmosomes. Mol. Cell. Biol. 24, 4351-4360
25. Wilhelmsen, K., Litjens, S.H., Kuikman, I., Margadant, C., van Rheenen, J. and Sonnenberg, A. (2007) Serine phosphorylation of the integrin β4 subunit is necessary for epidermal growth factor receptor induced hemidesmosome disruption. Mol. Biol. Cell 18, 3512-3522
26. Germain, E.C., Santos, T.M. and Rabinovitz, I. (2009) Phosphorylation of a novel site on the β4 integrin at the trailing edge of migrating cells promotes hemidesmosome disassembly. Mol. Biol. Cell 20, 56-67
27. Giancotti, F.G. (2007) Targeting integrin β4 for cancer and anti-angiogenic therapy. Trends Pharmacol. Sci. 28, 506-511
28. Dans, M., Gagnoux-Palacios, L., Blaikie, P., Klein, S., Mariotti, A. and Giancotti, F.G. (2001) Tyrosine phosphorylation of the β4 integrin cytoplasmic domain mediates Shc signaling to extracellular signal-regulated kinase and antagonizes formation of hemidesmosomes. J. Biol. Chem. 276, 1494-1502
29. Shaw, L.M. (2001) Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the α6β4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion. Mol. Cell. Biol. 21, 5082-5093
30. Yang, X., Kovalenko, O.V., Tang, W., Claas, C., Stipp, C.S. and Hemler, M.E. (2004) Palmitoylation supports assembly and function of integrin-tetraspanin complexes. J. Cell Biol. 167, 1231-1240 (Pubitemid 40066636)
31. Gagnoux-Palacios, L., Dans, M., Van't Hof, W., Mariotti, A., Pepe, A., Meneguzzi, G., Resh, M.D. and Giancotti, F.G. (2003) Compartmentalization of integrin aα6β4 signaling in lipid rafts. J. Cell Biol. 162, 1189-1196
32. Litjens, S.H., de Pereda, J.M. and Sonnenberg, A. (2006) Current insights into the formation and breakdown of hemidesmosomes. Trends Cell Biol. 16, 376-383 (Pubitemid 44062316)
33. Belkin, A.M. and Stepp, M.A. (2000) Integrins as receptors for laminins. Microsc. Res. Tech. 51, 280-301
34. Goldfinger, L.E., Hopkinson, S.B., deHart, G.W., Collawn, S., Couchman, J.R. and Jones, J.C. (1999) The aα3 laminin subunit, α6β4 and α3β1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin. J. Cell Sci. 112, 2615-2629
35. Stahl, S., Weitzman, S. and Jones, J.C. (1997) The role of laminin-5 and its receptors in mammary epithelial cell branching morphogenesis. J. Cell Sci. 110, 55-63 (Pubitemid 27057944)
36. Weaver, V.M., Lelievre, S., Lakins, J.N., Chrenek, M.A., Jones, J.C., Giancotti, F., Werb, Z. and Bissell, M.J. (2002) β4 Integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2, 205-216 (Pubitemid 41043976)
37. Friedrichs, K., Ruiz, P., Franke, F., Gille, I., Terpe, H.-J. and Imhof, B.A. (1995) High expression level of α6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res. 55, 901-906
38. Tagliabue, E., Ghirelli, C., Squicciarini, P., Aiello, P., Colnaghi, M.I. and Menard, S. (1998) Prognostic value of α6β4 integrin expression in breast carcinomas is affected by laminin production from tumor cells. Clin. Cancer Res. 4, 407-410
39. Mukhopadhyay, R., Theriault, R.L. and Price, J.E. (1999) Increased levels of α6 integrins are associated with the metastatic phenotype of human breast cancer cells. Clin. Exp. Metastasis 17, 325-332
40. Wewer, U.M., Shaw, L.M., Albrechtsen, R. and Mercurio, A.M. (1997) The integrin α6β1 promotes the survival of metastatic human breast carcinoma cells in mice. Am. J. Pathol. 151, 1191-1198
41. Demetriou, M.C. and Cress, A.E. (2004) Integrin clipping: a novel adhesion switch? J. Cell. Biochem. 91, 26-35
42. Chung, J. and Mercurio, A.M. (2004) Contributions of the α6 integrins to breast carcinoma survival and progression. Mol. Cells 17, 203-209 (Pubitemid 39137066)
43. Mercurio, A.M. and Rabinovitz, I. (2001) Towards a mechanistic understanding of tumor invasion: lessons from the α6β4 integrin. Semin. Cancer Biol. 11, 129-141
44. Giannelli, G., Astigiano, S., Antonaci, S., Morini, M., Barbieri, O., Noonan, D.M. and Albini, A. (2002) Role of the α3β1 and α6β4 integrins in tumor invasion. Clin. Exp. Metastasis 19, 217-223
45. Bachelder, R.E., Ribick, M.J., Marchetti, A., Falcioni, R., Soddu, S., Davis, K.R. and Mercurio, A.M. (1999) p53 inhibits α6β4 integrin survival signaling by promoting the caspase 3-dependent cleavage of Akt/PKB. J. Cell Biol. 147, 1063-1072
46. Dajee, M., Lazarov, M., Zhang, J.Y., Cai, T., Green, C.L., Russell, A.J., Marinkovich, M.P., Tao, S., Lin, Q., Kubo, Y. and Khavari, P.A. (2003) NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421, 639-643 (Pubitemid 36227672)
47. Guo, W., Pylayeva, Y., Pepe, A., Yoshioka, T., Muller, W.J., Inghirami, G. and Giancotti, F.G. (2006) β4 Integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 126, 489-502 (Pubitemid 44163602)
48. Nikolopoulos, S.N., Blaikie, P., Yoshioka, T., Guo, W. and Giancotti, F.G. (2004) Integrin β4 signaling promotes tumor angiogenesis. Cancer Cell 6, 471-483 (Pubitemid 39469983)
49. Fukata, Y., Iwanaga, T. and Fukata, M. (2006) Systematic screening for palmitoyl transferase activity of the DHHC protein family in mammalian cells. Methods 40, 177-182 (Pubitemid 44442975)
50. Mitchell, D.A., Vasudevan, A., Linder, M.E. and Deschenes, R.J. (2006) Protein palmitoylation by a family of DHHC protein S-acyltransferases. J. Lipid Res. 47, 1118-1127 (Pubitemid 43830703)
51. Hemler, M.E. (2003) Tetraspanin proteins mediate cellular penetration, invasion and fusion events, and define a novel type of membrane microdomain. Annu. Rev. Cell Dev. Biol. 19, 397-422
52. Boucheix, C. and Rubinstein, E. (2001) Tetraspanins. Cell. Mol. Life Sci. 58, 1189-1205
53. Miyado, K., Yamada, G., Yamada, S., Hasuwa, H., Nakamura, Y., Ryu, F., Suzuki, K., Kosai, K., Inoue, K., Ogura, A. et al. (2000) Requirement of CD9 on the egg plasma membrane for fertilization. Science 287, 321-324 (Pubitemid 30046763)
54. Le Naour, F., Rubinstein, E., Jasmin, C., Prenant, M. and Boucheix, C. (2000) Severely reduced female fertility in CD9-deficient mice. Science 287, 319-321
55. Kaji, K., Oda, S., Shikano, T., Ohnuki, T., Uematsu, Y., Sakagami, J., Tada, N., Miyazaki, S. and Kudo, A. (2000) The gamete fusion process is defective in eggs of CD9-deficient mice. Nat. Genet. 24, 279-282
56. Berditchevski, F. (2001) Complexes of tetraspanins with integrins: more than meets the eye. J. Cell Sci. 114, 4143-4151
57. Zhu, G.Z., Miller, B.J., Boucheix, C., Rubinstein, E., Liu, C.C., Hynes, R.O., Myles, D.G. and Primakoff, P. (2002) Residues SFQ (173-175) in the large extracellular loop of CD9 are required for gamete fusion. Development 129, 1995-2002 (Pubitemid 34874214)
58. Nakazawa, Y., Sato, S., Naito, M., Kato, Y., Mishima, K., Arai, H., Tsuruo, T. and Fujita, N. (2008) Tetraspanin family member CD9 inhibits Aggrus/podoplanin-induced platelet aggregation and suppresses pulmonary metastasis. Blood 112, 1730-1739
59. Nakamura, K., Mitamura, T., Takahashi, T., Kobayashi, T. and Mekada, E. (2000) Importance of the major extracellular domain of CD9 and the epidermal growth factor (EGF)-like domain of heparin-binding EGF-like growth factor for up-regulation of binding and activity. J. Biol. Chem. 275, 18284-18290
60. Furuya, M., Kato, H., Nishimura, N., Ishiwata, I., Ikeda, H., Ito, R., Yoshiki, T. and Ishikura, H. (2005) Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination: morphologic alteration and reduced expression of β1 integrin subsets. Cancer Res. 65, 2617-2625 (Pubitemid 40490060)
61. Miyake, M., Koyama, M., Seno, M. and Ikeyama, S. (1991) Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J. Exp. Med. 174, 1347-1354
62. Longo, N., Yáñez-Mó, M., Mittelbrunn, M., de la Rosa, G., Muñoz, M.L., Sánchez-Madrid, F. and Sánchez-Mateos, P. (2001) Regulatory role of tetraspanin CD9 in tumor-endothelial cell interaction during transendothelial invasion of melanoma cells. Blood 98, 3717-3726
63. Murayama, Y., Miyagawa, J., Oritani, K., Yoshida, H., Yamamoto, K., Kishida, O., Miyazaki, T., Tsutsui, S., Kiyohara, T., Miyazaki, Y. et al. (2004) CD9-mediated activation of the p46 Shc isoform leads to apoptosis in cancer cells. J. Cell Sci. 117, 3379-3388 (Pubitemid 39139921)
64. Carloni, V., Mazzocca, A. and Ravichandran, K.S. (2004) Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cells. Oncogene 23, 1566-1574 (Pubitemid 38406519)
65. Yauch, R.L. and Hemler, M.E. (2000) Specific interactions among transmembrane 4 superfamily (TM4SF) proteins and phosphatidylinositol 4-kinase. Biochem. J. 351, 629-637
66. Huang, C.L., Liu, D., Masuya, D., Kameyama, K., Nakashima, T., Yokomise, H., Ueno, M. and Miyake, M. (2004) MRP-1/CD9 gene transduction downregulates Wnt signal pathways. Oncogene 23, 7475-7483 (Pubitemid 39389689)
67. Shi, W., Fan, H., Shum, L. and Derynck, R. (2000) The tetraspanin CD9 associates with transmembrane TGF-α and regulates TGF-α-induced EGF receptor activation and cell proliferation. J. Cell Biol. 148, 591-602
68. Stipp, C.S., Orlicky, D. and Hemler, M.E. (2001) FPRP: a major, highly stoichiometric, highly specific CD81 and CD9-associated protein. J. Biol. Chem. 276, 4853-4862
69. Charrin, S., Le Naour, F., Oualid, M., Billard, M., Faure, G., Hanash, S.M., Boucheix, C. and Rubinstein, E. (2001) The major CD9 and CD81 molecular partner: identification and characterization of the complexes. J. Biol. Chem. 276, 14329-14337
70. Stipp, C.S., Kolesnikova, T.V. and Hemler, M.E. (2001) EWI-2 is a major CD9 and CD81 partner, and member of a novel Ig protein subfamily. J. Biol. Chem. 276, 40545-40554
71. Kolesnikova, T.V., Stipp, C.S., Rao, R.M., Lane, W.S., Luscinskas, F.W. and Hemler, M.E. (2004) EWI-2 modulates lymphocyte integrin α4β1 functions. Blood 103, 3013-3019 (Pubitemid 38451674)
72. Kolesnikova, T.V., Kazarov, A.R., Lemieux, M., Lafleur, M.A., Kesari, S., Kung, A.L. and Hemler, M.E. (2008) Glioblastoma suppression by tetraspanin partner protein EWI-2 in vitro and in vivo. Neoplasia 11, 77-86
73. Junge, H.J., Yang, S., Burton, J.B., Paes, K., Shu, X., French, D.M., Costa, M., Rice, D.S. and Ye, W. (2009) TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4/β-catenin signaling. Cell 139, 299-311
74. Poulter, J.A., Ali, M., Gilmour, D.F., Rice, A., Kondo, H., Hayashi, K., Mackey, D.A., Kearns, L.S., Ruddle, J.B., Craig, J.E. et al. (2010) Mutations in TSPAN12 cause autosomal-dominant familial exudative vitreoretinopathy. Am. J. Hum. Genet. 86, 248-253
75. Ye, X., Wang, Y. and Nathans, J. (2010) The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease. Trends Mol. Med. 16, 417-425
76. Nikopoulos, K., Gilissen, C., Hoischen, A., van Nouhuys, C.E., Boonstra, F.N., Blokland, E.A., Arts, P., Wieskamp, N., Strom, T.M., Ayuso, C. et al. (2010) Next-generation sequencing of a 40 Mb linkage interval reveals TSPAN12 mutations in patients with familial exudative vitreoretinopathy. Am. J. Hum. Genet. 86, 240-247
77. Xu, D., Sharma, C. and Hemler, M.E. (2009) Tetraspanin12 regulates ADAM10-dependent cleavage of amyloid precursor protein. FASEB J. 23, 3674-3681
78. Moss, M.L., Stoeck, A., Yan, W. and Dempsey, P.J. (2008) ADAM10 as a target for anti-cancer therapy. Curr. Pharm. Biotechnol. 9, 2-8
79. Lee, S.B., Schramme, A., Doberstein, K., Dummer, R., Abdel-Bakky, M.S., Keller, S., Altevogt, P., Oh, S.T., Reichrath, J., Oxmann, D. et al. (2010) ADAM10 is upregulated in melanoma metastasis compared with primary melanoma. J. Invest. Dermatol. 130, 763-773